These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25175004)

  • 1. Continuing debate: efficacy and safety of misoprostol dosing.
    Sheibani L; Wing DA
    BJOG; 2015 Mar; 122(4):477. PubMed ID: 25175004
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 μg of intravaginal misoprostol for the induction of labour: Safety of 25-μg intravaginal tablet of misoprostol for the induction of labour.
    Meller CH; Izbizky GH; Otaño L
    BJOG; 2015 Sep; 122(10):1421-2. PubMed ID: 26307476
    [No Abstract]   [Full Text] [Related]  

  • 3. Misoprostol vaginal insert for induction of labor: a delivery system with accurate dosing and rapid discontinuation.
    Stephenson ML; Hawkins JS; Powers BL; Wing DA
    Womens Health (Lond); 2014 Jan; 10(1):29-36. PubMed ID: 24328596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dinoprostone compared with misoprostol for cervical ripening for induction of labor at term.
    Church S; Van Meter A; Whitfield R
    J Midwifery Womens Health; 2009; 54(5):405-411. PubMed ID: 19720343
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing the efficacy and safety of misoprostol: a meta-analysis comparing 25 versus 50 micrograms of intravaginal misoprostol for the induction of labour.
    McMaster K; Sanchez-Ramos L; Kaunitz AM
    BJOG; 2015 Mar; 122(4):468-76. PubMed ID: 24989790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical ripening and induction of labor with intravaginal misoprostol and Foley catheter cervical traction.
    Kashanian M; Akbarian AR; Fekrat M
    Int J Gynaecol Obstet; 2006 Jan; 92(1):79-80. PubMed ID: 16246342
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial.
    Denguezli W; Trimech A; Haddad A; Hajjaji A; Saidani Z; Faleh R; Sakouhi M
    Arch Gynecol Obstet; 2007 Aug; 276(2):119-24. PubMed ID: 17219155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized clinical trial to compare the efficacy of different doses of intravaginal misoprostol with intracervical dinoprostone for cervical ripening and labor induction.
    Saxena P; Puri M; Bajaj M; Mishra A; Trivedi SS
    Eur Rev Med Pharmacol Sci; 2011 Jul; 15(7):759-63. PubMed ID: 21780543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the optimal duration of oral misoprostol treatment for cervical ripening?
    Drakopoulos P; Duyck C; Gayet-Ageron A; Fernandez S; Irion O; Martinez de Tejada B
    J Matern Fetal Neonatal Med; 2017 Jun; 30(12):1494-1499. PubMed ID: 27493019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal misoprostol in managing premature rupture of membranes.
    Ayad IA
    East Mediterr Health J; 2002; 8(4-5):515-20. PubMed ID: 15603033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial of vaginal misoprostol versus dinoprostone vaginal insert for labor induction.
    Garry D; Figueroa R; Kalish RB; Catalano CJ; Maulik D
    J Matern Fetal Neonatal Med; 2003 Apr; 13(4):254-9. PubMed ID: 12854927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of efficacy and safety of sublingual misoprostol with intracervical dinoprostone gel for cervical ripening in prelabour rupture of membranes after 34 weeks of gestation.
    Jha N; Sagili H; Jayalakshmi D; Lakshminarayanan S
    Arch Gynecol Obstet; 2015 Jan; 291(1):39-44. PubMed ID: 25055933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between vaginal and sublingual misoprostol 50 µg for cervical ripening prior to induction of labor: randomized clinical trial.
    Conde A; Ben S; Tarigo J; Artucio S; Varela V; Grimaldi P; Sosa C; Alonso J
    Arch Gynecol Obstet; 2017 Apr; 295(4):839-844. PubMed ID: 28204882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral misoprostol vs. vaginal misoprostol for cervical ripening and labor induction.
    Adam I; Hassan OA; Elhassan EM
    Int J Gynaecol Obstet; 2005 May; 89(2):142-3. PubMed ID: 15847879
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized trial of preinduction cervical ripening: misoprostol vs oxytocin.
    Fonseca L; Wood HC; Lucas MJ; Ramin SM; Phatak D; Gilstrap LC; Yeomans ER
    Am J Obstet Gynecol; 2008 Sep; 199(3):305.e1-5. PubMed ID: 18771993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between vaginal misoprostol and cervical dinoprostone for cervical ripening and labor induction.
    Neiger R; Greaves PC
    Tenn Med; 2001 Jan; 94(1):25-7. PubMed ID: 11194687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravaginal and intracervical misoprostol for cervical ripening of labor in primiparas.
    Ding DC; Su HY; Chu TW
    Int J Gynaecol Obstet; 2003 Aug; 82(2):209-11. PubMed ID: 12873783
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomization of two dosing regimens of vaginal misoprostol for cervical ripening and labor induction in a low resource setting.
    Adeniyi AA; Odukogbe AA; Olayemi A; Oladokun O; Adeniji AO; Aimakhu CO; Enakpene C
    Niger J Clin Pract; 2014; 17(3):287-91. PubMed ID: 24714004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of labour at term with misoprostol: the experience of a Tunisian maternity ward].
    Ouerdiane N; Tlili N; Othmani K; Daaloul W; Masmoudi A; Hamouda SB; Bouguerra B
    Pan Afr Med J; 2016; 24():28. PubMed ID: 27583092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotec and the FDA.
    Gaskin IM
    Midwifery Today Int Midwife; 2013; (107):8-14. PubMed ID: 24133793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.